Senior insider sale
ACTUATE THERAPEUTICS, INC. — senior position signals high conviction
$2.13M
280K shares
What this filing means
KAIROS VENTURE PARTNERS II, L.P. plans to sell 280K shares of ACTUATE THERAPEUTICS, INC. valued at approximately $2.13M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/11/2025ACC: 0001683168-25-009069
DirectorOther
Since Aug 2024
280K
Shares to sell
$2.13M
Approx. market value
280K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Investment, Pre-IPO
Cash
4/30/2019
280KTotal acquired280K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/30/2019 | Private Investment, Pre-IPO Cash | 280K | — |
| Total | 280K | ||
Planned & Completed Dispositions1
NASDAQ Global MarketPlanned
Units to sell
280K
Market value
$2.13M
12/11/2025
Total
Units
280K
Value
$2.13M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/11/2025 | 280K | $2.13M | NASDAQ Global Market | Planned |
| Total | 280K | $2.13M | ||